›› 2011, Vol. 6 ›› Issue (10): 832-838.

• 综述 • Previous Articles     Next Articles

Recent Progress in Detection and Prevention of Clopidogrel Resistance

SHI Hong-Ting ZHOU Bo-Rong   

  • Received:2011-05-01 Revised:2011-04-01 Online:2011-10-20 Published:2011-10-20
  • Contact: ZHOU Bo-Rong

氯吡格雷抵抗的检测与防治进展

石红婷,周伯荣

  

  1. 广东省广州市广州医学院第三附属医院神经内科
  • 通讯作者: 周伯荣

Abstract:

Clopidogrel is a widely used antiplatelet aggregation drug. However, Clopidogrel-induced platelet inhibition is patient-specific. The benefits of using clopidogrel are not guaranteed. Various platelet-function tests include light transmission aggregometry(LTA), and platelet function analyzer 100(PFA-100), and flow cytometer(FCM). The prevention of clopidogrel resistance has versatile measures. The possible measures include avoiding drug interactions, augment dosage and therapeutic alliance.

Key words: Clopidogrel; Clopidogrel resistance; Diagnostic tests; routine

摘要: 氯吡格雷是目前广泛应用的抗血小板药物,其对血小板的抑制具有个体差异性。近来氯吡格雷抵抗受到了越来越多的关注,它的检测方法有透光率集合度测定、血小板功能分析仪、全血流式细胞仪等。防治氯吡格雷抵抗的对策是多方面的,主要有避免药物相互作用、增加剂量或联合治疗等。

关键词: 氯吡格雷; 氯吡格雷抵抗; 诊断试验; 常规